Cost-effectiveness of filgrastim and pegfilgrastim as primary prophylaxis against febrile neutropenia in lymphoma patients

Nina Lathia, Pierre K. Isogai, Carlo De Angelis, Thomas J. Smith, Matthew Cheung, Nicole Mittmann, Jeffrey S. Hoch, Scott Walker

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-effectiveness of filgrastim and pegfilgrastim as primary prophylaxis against febrile neutropenia in lymphoma patients'. Together they form a unique fingerprint.

Medicine & Life Sciences